Glaucoma Today

When pressure rebounds, the plan must evolve.

In this GT Case Files discussion, surgeons weigh how to manage a patient with retinal leukemic infiltrates, macular edema, steroid-induced glaucoma, and an early postoperative IOP spike after tube shunt surgery.

The stakes are high, with advanced optic nerve damage and the fellow eye awaiting intervention. Should the team adjust medications, revise the surgical strategy, or choose a different approach altogether?

Read the case to see how experts navigate timing, risk, and vision preservation in a complex clinical scenario here: https://ow.ly/eXmY50ZeGaB

Could oral sedation reshape glaucoma surgery?

As anesthesia resources tighten and ASC efficiency becomes increasingly important, Zachary Vest, MD, explores a practical shift in surgical anesthesia.

The article examines where oral sedation may fit, which cases may be best suited for it, and how patient selection can shape the experience.

It also highlights the small moments that can influence anxiety in the OR, from draping to microscope light exposure.

Read the full article in Glaucoma Today for practical pearls on bringing oral sedation into glaucoma practice here: https://ow.ly/yvvE50ZbjEp

What if MIGS outcomes hinge on what we cannot routinely see?

In this Diagnostic Advances article, Osamah Saeedi, MD, MS, and Saige Oechsli, BS, examine episcleral angiography and its potential role in assessing distal aqueous outflow. The piece reframes trabecular bypass surgery around a key question: not simply whether it can lower IOP, but which eyes are most likely to respond.

Emerging imaging approaches may help bring outflow physiology into sharper clinical focus. Read the article to explore how this evolving diagnostic frontier could shape precision glaucoma surgery here: https://ow.ly/pVgi50Z8XnA

When IOP drops, the story is often deeper than the number.

Hypotony after glaucoma surgery can appear subtle at the slit lamp, yet its sequelae may threaten long-term vision.

In this Diagnostic Advances article, Poojitha Balakrishnan, MD, MPH, PhD, and Jithin Yohannan, MD, MPH, explore how OCT, A- and B-scan ultrasound, and UBM can reveal what clinical examination may miss.

From macular folds to anterior segment clues, imaging can help clinicians identify the cause and guide next steps.

Read the full article to see how multimodal imaging sharpens the evaluation of postoperative hypotony here: https://ow.ly/4Y7f50Z8bI8

Recap key insights from a recent educational webinar on how integrating OCT with visual field testing can improve decision-making across all stages of glaucoma.

Learn how to bridge structure and function in daily practice: https://ow.ly/iFwH50Z4e29

Glaucoma Today was proud to be on site at the European Glaucoma Society (EGS) Annual Meeting, engaging with industry and physician partners from around the world. From capturing expert-driven digital content with our industry collaborators to strengthening our connections with international colleagues, the meeting provided a valuable opportunity to further GT’s commitment to serving the global glaucoma community. Thank you to everyone who helped make this year's meeting such a success.

Bleb appearance only tells part of the story. In glaucoma filtration surgery, AS-OCT can reveal and quantify the internal architecture that may determine long-term surgical success, from bleb height and wall reflectivity to scleral flap and sclerostomy patency.

These objective metrics could help clinicians identify early signs of scarring, stratify risk, and intervene before a bleb fails. As imaging advances, AS-OCT may become an increasingly practical tool for postoperative decision-making and research in glaucoma surgery.

Read more here: https://ow.ly/5axZ50Z5eu8.

Could glaucoma surgery become more genetically guided? In this GT article, Erin A. Boese, MD, explores how targeted genetic assessment may inform surgical planning in select patients with autosomal dominant glaucoma.

MYOC-associated juvenile OAG may respond especially well to trabecular meshwork–targeted procedures such as GATT, whereas mutations linked to normal-tension glaucoma may warrant consideration of lower IOP targets. The takeaway: DNA testing will not replace clinical judgment, but it may sharpen prognosis and personalize surgical strategy.

Read the full article here: https://ow.ly/mziY50Z3iPh .